MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 105 filers reported holding MOLECULAR TEMPLATES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,390,401 | +26.3% | 11,230,003 | 0.0% | 0.08% | +24.2% |
Q1 2023 | $4,266,278 | +15.3% | 11,230,003 | -0.4% | 0.06% | +26.5% |
Q4 2022 | $3,699,185 | -56.2% | 11,278,003 | 0.0% | 0.05% | -59.5% |
Q3 2022 | $8,455,000 | -17.8% | 11,278,003 | 0.0% | 0.12% | -16.6% |
Q2 2022 | $10,281,000 | -73.1% | 11,278,003 | +1.8% | 0.14% | -67.3% |
Q1 2022 | $38,219,000 | -10.4% | 11,078,003 | +1.8% | 0.44% | +0.9% |
Q4 2021 | $42,642,000 | -41.6% | 10,878,003 | 0.0% | 0.44% | -40.6% |
Q3 2021 | $72,991,000 | -3.1% | 10,878,003 | +13.0% | 0.74% | +0.8% |
Q2 2021 | $75,296,000 | -26.8% | 9,628,621 | +18.2% | 0.74% | -32.4% |
Q1 2021 | $102,829,000 | +70.8% | 8,148,105 | +27.1% | 1.09% | +57.7% |
Q4 2020 | $60,211,000 | +9.8% | 6,412,331 | +27.7% | 0.69% | -9.0% |
Q3 2020 | $54,840,000 | +14.4% | 5,021,996 | +44.4% | 0.76% | +11.6% |
Q2 2020 | $47,951,000 | +24.0% | 3,477,240 | +19.5% | 0.68% | -9.5% |
Q1 2020 | $38,682,000 | +113.5% | 2,910,640 | +124.6% | 0.75% | +161.3% |
Q4 2019 | $18,120,000 | – | 1,295,687 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,137,991 | $8,381,000 | 6.85% |
ACUTA CAPITAL PARTNERS, LLC | 322,500 | $1,264,000 | 0.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,021,317 | $4,004,000 | 0.46% |
BVF INC/IL | 3,129,599 | $12,268,000 | 0.44% |
Bellevue Group AG | 10,878,003 | $42,642,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 1,374,047 | $5,386,000 | 0.42% |
Endurant Capital Management LP | 268,375 | $1,052,000 | 0.25% |
Abingworth LLP | 200,000 | $780,000 | 0.19% |
Parkman Healthcare Partners LLC | 147,728 | $579,000 | 0.13% |
GSA CAPITAL PARTNERS LLP | 145,329 | $570,000 | 0.07% |